By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aurigene Discovery Technologies Limited 

39-40, KIADB Industrial Area
Electronic City Phase II, Hosur Road
Bangalore    560 100  India
Phone: 91-80-2852-1314 Fax: 91-80-2852-6285


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Aurigene Discovery Technologies Limited And Orion Corporation Announce Research, Collaboration And Option Agreement For Rights To Aurigene's Epigenetics Program For Pan BET And Selective BET Bromodomain Inhibitors 6/24/2014 7:37:26 AM
Aurigene Discovery Technologies Limited And Pierre Fabre Announce A Licensing Agreement For A New Cancer Therapeutic In Immuno-Oncology : AUNP12, An Immune Checkpoint Modulator Targeting The PD-1 Pathway 2/12/2014 9:29:48 AM
Aurigene Discovery Technologies Limited and Debiopharm Group™ Report Nomination of Development Candidate Debio 0617B in Oncology 6/20/2013 8:51:12 AM
Aurigene Discovery Technologies Limited and Debiopharm Report Nomination of Development Candidate Debio 0617B in Oncology 6/19/2013 11:55:25 AM
Debiopharm and Aurigene Discovery Technologies Limited Sign Agreement for the Development and Commercialisation of Debio 1142, A Novel Inhibitor of an Undisclosed Oncology Pathway 4/14/2011 12:42:40 PM
Debiopharm and Aurigene Discovery Technologies Limited Nominate Development Candidate 9/13/2010 3:29:04 PM
Dr. Reddy's Laboratories Ltd. (RDY) Receives Approval for Three INDs and Announces Reorganization of Its Drug Discovery Operations; Discovery Research to Fold Into Aurigene Discovery Technologies Limited 5/22/2009 7:13:42 AM
Debiopharm and Aurigene Discovery Technologies Limited Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway 11/20/2008 8:16:36 AM
Aurigene Discovery Technologies Limited Announces Discovery Collaborations With Forest Laboratories, Inc. (FRX) On Obesity Targets 2/2/2007 7:28:34 PM
Aurigene Discovery Technologies Limited And Merck Serono Enter A Discovery Collaboration To Identify Therapeutics For Autoimmune Disorders 2/2/2007 3:10:53 PM
12
//-->